About this trial
The study aims to evaluate the effect of ginger supplementation on inflammatory cytokines and markers of oxidative stress in patients with Coronary Artery Disease (CAD). A longitudinal double-blind randomized clinical trial will be carried out, involving CAD participants for two months.
Eligibility criteria
Qualifiers
Both sexes
Over 18 years of age;
Diagnosed with Coronary Artery Disease: confirmed by coronary angiography, coronary computed tomography angiography, or functional testing with ischemic load);
Participants who are asymptomatic or have angina limited to functional class III will be considered;
Disqualifiers
Unstable Coronary Artery Disease;
Pre-operative coronary artery bypass grafting or awaiting elective angioplasty;
Unstable angina;
NYHA functional class III or higher;
Trial design
Treatments tested in this trial
- Ginger
- Placebo
Treatment groups
Sponsors and collaborators
Universidade Federal Fluminense
Lead sponsor
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Collaborator
Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Collaborator